- Home
- RCKT vs BALY Comparison
RCKT vs BALY Comparison
Compare RCKT & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | BALY |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | 202 | 11700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 511.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | RCKT | BALY |
|---|---|---|
| Price | $3.94 | $11.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $29.73 | $12.80 |
| AVG Volume (30 Days) | ★ 4.2M | 60.1K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,436,189,000.00 |
| Revenue This Year | N/A | $21.50 |
| Revenue Next Year | $64.28 | $5.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.19 | $8.46 |
| 52 Week High | $8.26 | $20.74 |
Technical Indicators
Market Signals| Indicator | RCKT | BALY |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 52.96 |
| Support Level | $2.95 | $8.91 |
| Resistance Level | $4.08 | $14.85 |
| Average True Range (ATR) | 0.22 | 0.77 |
| MACD | 0.03 | 0.27 |
| Stochastic Oscillator | 78.07 | 90.54 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.